Translation of "impotence drug " (English → French) :

impotence drug | anti-impotence drug | impotence agent | anti-impotence agent | male impotence agent | erection drug

drug addiction [ drug abuse | drug-taking | fight against drugs | drug addicts(UNBIS) ]

EU Action Plan on Drugs | EU Action Plan to Combat Drugs | EU Drugs Action Plan | European Union Action Plan on Drugs | European Union Action Plan to Combat Drugs | European Union Drugs Action Plan

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

drug traffic [ drug trafficking | narcotics traffic | Drugs economy(STW) ]

Cooperation Group to Combat Drug Abuse and Illicit Trafficking in Drugs | Partial Agreement Cooperation Group to Combat Drug Abuse and Illicit Trafficking in Drugs | Pompidou Group

European Monitoring Centre for Drugs and Drug Addiction [ EMCDDA [acronym] European Monitoring Centre for Drugs ]

antihyperlipidaemic drug | antihyperlipidemic drug | hypolipidaemic drug | hypolipidemic drug

extra-label drug use | extra label drug use | extralabel drug use | off label drug use | off-label drug use | extralabel use | extra label use | extra-label use | off label use | off-label use

prescription drug | prescription medication | prescription medicine | prescribed drug | ethical drug | ethic drug | legend drug

If you look at the well-recorded side effects of these drugs, which I appreciate are rare but nonetheless do exist, they are the following: impotence, gynecomastia (men growing breasts—that'll thrill them), confusion, hallucinations, grand mal seizures, anaphylactic shock, jaundice, and most important, serious blood disorders, including thrombocytopenia, pancytopenia, leukopenia, agranulocytosis and aplastic anaemia, some of which are irreversible on stopping the drug.

Most persons with MS will require different forms of drug treatment to deal with the many symptoms of the illness - fatigue, spasticity, pain, impotence, incontinence or depression.

Honourable senators, in fact, time has shown that there has been no sinking of teeth, no outrageous increases in drug prices and no impotent prices review board despite all the Liberal opposition at the time.

Not only were we warned that the price of patented drugs would increase by $1 billion over 10 or 15 years, we were also warned that the generic companies would suffer tremendously and that the Patented Medicines Prices Review Board would be impotent in controlling drug prices.